Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...
Why this 2-year-old San Francisco company filed for an IPO © 2026 American City Business Journals. All rights reserved. Use ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe Therapeutics Inc., a molecular engineering company creating the most advanced technologies for CRISPR-based genetic medicine, today announced the completion of ...
Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, is seeking to raise as much as $107.2 million in a US initial public offering.
Both colors are reduced.
A slew of biotechs have disclosed their IPO plans in July, with Attovia Therapeutics , a biotech focused on immune-mediated ...
12don MSNOpinion
I tested the Flowtica Scribe. It looked good until I compared it to Gemini and a voice recorder
It has the write idea though ...
The Kindle Scribe Without Front Light should be an ideal e-ink notebook, but it's limits are hard to ignore. Find out more in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results